Human AssistCare
Human AssistCare, the PSP and DCT division of ItaliAssistenza SpA, designs and delivers patient support programs and decentralized clinical trials for pharmaceutical, biotech, MedDev, and CRO clients in Italy, combining a 200+ clinical operator network with its cloud-native Digital Health Platform.
- Company typePrivate
- Founded2004
- HeadquartersBresso, Italy
- Headcount51–100
- GTM typeB2B
- OfferingServices
What Human AssistCare does
Human AssistCare is the specialized Patient Support Programs (PSP) and Decentralized Clinical Trials (DCT) division of ItaliAssistenza SpA, an Italian private limited company headquartered in Reggio Emilia with operational offices in Bresso (Milan). The company designs, delivers, and monitors structured programs that combine in-home healthcare services from a credentialed clinical network with digital health tools, targeting therapeutic adherence and continuity of care for patients with chronic or rare diseases. Its stated client base consists of pharmaceutical, biotech, and MedDev sponsors, Contract Research Organizations (CROs), hospital clinical centers, and specialty healthcare facilities, with all current operations confined to Italy.
The technical core is the Digital Health Platform (DHP), a cloud-native platform built on a microservices architecture and exposed through documented APIs for integration with third-party systems and medical devices. The platform supports telemonitoring via wearables, telemedicine and telediagnostics (including ECG, Holter, and echocardiography with remote reporting), a digital patient dossier capturing vital parameters, Patient Reported Outcomes (PRO), and pathology indices, and integration pathways for Digital Therapeutics (DTx) and Software as a Medical Device (SaMD). Services are bundled into three lines: traditional PSPs, digitally enabled Digital PSPs (incorporating AI and DTx), and DCTs that shift clinical trial activity into the patient's home. The company cites over 50 delivered programs across 30 therapeutic areas, more than 100,000 patients supported, and a 97% reported therapeutic adherence rate.
Commercially, Human AssistCare runs an enterprise field-sales GTM targeting large B2B buyers, with no disclosed pricing, no public revenue figures, and no external funding events in the input data. The business is funded organically through its sole-shareholder parent, ItaliAssistenza SpA, which carries Euro 600,000 in stated share capital. The company holds ISO 9001:2015 (quality) and ISO/IEC 27001:2022 (information security, dated January 2024) certifications, asserts full GDPR compliance, and claims HIPAA compliance, collectively positioning it for regulated pharma and CRO procurement processes.
Human AssistCare firmographics
Firmographics- Name
- Human AssistCare
- Legal name
- ItaliAssistenza SpA
- Website
- https://humanassistcare.it
- Company type
- Private
- Founded year
- 2004
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Human AssistCare, the PSP and DCT division of ItaliAssistenza SpA, designs and delivers patient support programs and decentralized clinical trials for pharmaceutical, biotech, MedDev, and CRO clients in Italy, combining a 200+ clinical operator network with its cloud-native Digital Health Platform.
- Ownership category
- akta.pro rank
Human AssistCare industry classification
Industry- Product category
- Patient Support and Clinical Trial Services
- NAICS
- Home Health Care Services (62161), Home Health Care Services (621610)
- SIC
- Services-Home Health Care Services (8082), Services-Prepackaged Software (7372)
- akta.pro primary industry
- Decentralized/Hybrid Trial Enablement (DCT) Platforms (HLACAOAL)
- akta.pro secondary industries
- Remote Diagnostics & Point-of-Care (Connected Testing, Home Lab Devices) (HLACAPAK), Therapeutic Companion Apps (Drug-Device-Digital Combination) (HLACANAH)
Keywords
Where Human AssistCare is headquartered
LocationHeadquarters
- HQ city
- Bresso
- HQ country
- Italy
- HQ region
- Europe
Offices2 records
Markets served
Human AssistCare business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- Patient Support Programs (PSP): Design, development, and delivery of structured Patient Support Programs for pharmaceutical companies to improve therapeutic adherence and quality of life for patients with chronic or rare diseases. Services include home healthcare, teleconsultations, educational materials, psychological counseling, and logistics support.
- Digital Patient Support Programs (Digital PSP): Advanced digital health solutions integrated with human touch, including telemonitoring, digital patient dossiers, AI and Digital Therapeutics integration, telemedicine services, and educational digital content.
- Decentralized Clinical Trials (DCT): Home-based clinical trial services including country service management, home healthcare services, clinician support, assisted accompaniment to clinical centers, and logistics services for clinical studies.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels2 records
Human AssistCare product offering
Product offeringCore offering
Human AssistCare designs, delivers, and monitors Patient Support Programs (PSP) and Decentralized Clinical Trials (DCT) for pharmaceutical, biotech, MedDev, CRO, and hospital clients. Services combine home-based healthcare delivered by qualified clinical operators with a proprietary cloud-native Digital Health Platform (DHP) that enables telemedicine, telemonitoring, wearables integration, and Real World Evidence data collection to improve therapeutic adherence in chronic and rare disease patients.
Product overview
Human AssistCare is a division of ItaliAssistenza SpA offering an integrated portfolio of healthcare services combining home healthcare with digital health solutions. The core offerings include: (1) PSP – Patient Support Programs for chronic and rare disease patients, (2) Digital PSP – digitally-enhanced patient support with telemedicine, AI, and Digital Therapeutics, and (3) DCT – Decentralized Clinical Trials enabling at-home clinical study activities. These services are powered by the Digital Health Platform (DHP), a cloud-native platform that coordinates home care delivery, remote monitoring, and data collection across all programs.
Differentiator
Problem solved
Functional benefit
Products and services
- Patient Support Programs (PSP) Structured patient support programs designed and delivered for pharmaceutical, biotech, and MedDev companies to improve therapeutic adherence and quality of life for patients with chronic or rare diseases. Combines home healthcare services, teleconsultations, educational materials, psychological counseling, and personalized logistics support.
- Digital Patient Support Programs (Digital PSP) Advanced digital-health-enabled patient support programs for pharmaceutical and biotech clients, integrating telemedicine, telemonitoring with wearables, AI and Digital Therapeutics (DTx), patient digital dossiers, and educational digital content with human touch clinical support for continuous personalized care and Real World Evidence generation.
- Decentralized Clinical Trials (DCT) Decentralized clinical trial services for CROs and sponsors that move part of clinical study activities to the patient's home, including country service management, home healthcare nursing, clinician support, assisted accompaniment to clinical centers, and logistics services, reducing hospital visits and improving enrollment, accessibility, and cost efficiency.
- Digital Health Platform (DHP) Cloud-native digital health platform with microservice architecture that coordinates home-based and remote patient service delivery for PSP and DCT programs. Integrates with third-party systems, PACS, and medical devices via documented APIs, supports televisits and teleconsultations, telemonitoring, digital patient dossiers, and aggregated anonymized KPI and Real World Evidence reporting for partner companies.
Quantifiable outcome
- 97% therapeutic adherence rate among patients in their programs
- +3 more outcomes
Companies that use Human AssistCare
Customer profileNamed customers6 records
Segments3 records
Ideal customer profiles3 records
Human AssistCare technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
AI capability5 records
Feature6 records
Human AssistCare partnerships and signals
Strategic signalScale indicators7 records
Recent moves5 records
Expansion highlights5 records
Human AssistCare competitors and assessment
Company assessmentBroad incumbents
- ICON plc: ICON plc is a major global CRO offering clinical trial services, decentralized trial capabilities, and patient-centric solutions. It competes with Human AssistCare for pharma DCT and PSP work as part of a much broader services portfolio.
- IQVIA: IQVIA is the world's largest CRO with extensive DCT, patient support, and real-world evidence capabilities. While far broader in scope, it directly competes for the same pharma PSP and DCT budgets that Human AssistCare targets.
Emerging players
- Doccla: Doccla is a European virtual ward and remote patient monitoring provider delivering hybrid home-monitoring services to the NHS and pharma-sponsored programs. Its hybrid model and clinical-operator network overlap with Human AssistCare's PSP/Digital PSP offering.
Direct peers
- Castor: Castor provides an eClinical platform with ePRO, eCOA, and DCT modules widely used by CROs and pharma. It overlaps with Human AssistCare's DHP in clinical data capture and DCT enablement.
- ObvioHealth: ObvioHealth operates a DCT platform and home-visit network for hybrid and fully decentralized clinical trials, serving pharma and biotech sponsors with a comparable technology-plus-operators model.
- Science 37: Science 37 is a DCT-native provider combining a patient-facing technology platform with in-home and mobile clinician networks to run fully decentralized clinical trials, directly comparable to Human AssistCare's hybrid PSP/DCT model for pharma customers.
- Clario: Clario (formed via ERT/Bioclinica merger) supplies eCOA, cardiac safety, imaging, and decentralized trial technology used across the pharma industry. It competes with Human AssistCare in DCT technology, remote diagnostics, and clinical outcome assessments.
- Medable: Medable is a leading DCT enablement platform providing eCOA, ePRO, telehealth, and remote monitoring technology for decentralized clinical trials. It competes directly with Human AssistCare's DCT offering and DHP technology layer, especially for pharma-sponsored trials.
Regional players
- DomusVi Italia: DomusVi Italia operates home care and residential care services across Italy, including skilled home health assistance. It is comparable to Human AssistCare for the in-home healthcare delivery side of PSPs, though without the DCT and digital platform layer.
- Korian Italia: Korian Italia is one of the largest home care and senior services operators in Italy, providing skilled home health and assistance services. It is comparable to Human AssistCare's home-based PSP delivery in the Italian market, though focused on elder services rather than pharma-sponsored PSP.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Human AssistCare social profiles
Digital presenceHuman AssistCare compliance and trust
Trust signalCompliance4 records
Human AssistCare financial estimates
Financial estimateRevenue estimate
Valuation estimate
Human AssistCare leadership team
Management profileNumber of profiles
Profiles5 records
Human AssistCare funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Human AssistCare M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Human AssistCare
What does Human AssistCare do?
Human AssistCare designs, delivers, and monitors Patient Support Programs (PSP) and Decentralized Clinical Trials (DCT) for pharmaceutical, biotech, MedDev, CRO, and hospital clients. Services combine home-based healthcare delivered by qualified clinical operators with a proprietary cloud-native Digital Health Platform (DHP) that enables telemedicine, telemonitoring, wearables integration, and Real World Evidence data collection to improve therapeutic adherence in chronic and rare disease patients.
Is Human AssistCare a public or private company?
Human AssistCare is a private company. It is classified as corporate owned and is currently operating.
When was Human AssistCare founded?
Human AssistCare was founded in 2004. It employs 51 to 100 people.
Where is Human AssistCare based?
Human AssistCare is headquartered in Bresso, Italy, in the Europe region.
How does Human AssistCare make money?
Three revenue lines are on record. Patient Support Programs (PSP) is the primary driver. The others are digital Patient Support Programs (Digital PSP) and decentralized Clinical Trials (DCT).
Who are Human AssistCare's main competitors?
Broad incumbents on record are ICON plc and IQVIA. Doccla is listed as an emerging player. Direct peers are Castor, ObvioHealth, Science 37, Clario and Medable. Regional players are DomusVi Italia and Korian Italia.
Does Human AssistCare have an API?
Yes. The Digital Health Platform (DHP) is described as a cloud-native platform based on microservices architecture, integrable via documented APIs with third-party systems and medical devices. The API enables interoperability with external third-party systems and integration with medical devices for data exchange and coordination of home care and remote services.
What industry is Human AssistCare in?
Human AssistCare's product category is Patient Support and Clinical Trial Services. Its primary akta.pro industry code is HLACAOAL, Decentralized/Hybrid Trial Enablement (DCT) Platforms, with a secondary code of HLACAPAK, Remote Diagnostics & Point-of-Care (Connected Testing, Home Lab Devices). Its NAICS code is 62161 and its SIC code is 8082.